Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

Key Takeaways Avanos Medical sees growth from SNS and PMR, with strong demand in enteral feeding and RFA.AVNS boosts portfolio via Nexus deal, divestitures and exit of underperforming segments.Avanos Medical faces tariff costs, FX risks, and weaker surgical pain and GAME READY performance.Avanos Medical, Inc. (AVNS) is well-poised for growth in the coming quarters, courtesy of its impressive product line. The optimism, led by a decent fourth-quarter fiscal 2025 performance and continued robust product perfo ...